• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视网膜分支静脉阻塞:流行病学、发病机制、危险因素、临床特征、诊断和并发症。文献更新。

Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature.

机构信息

Barts and the London School of Medicine and Dentistry, Queen Mary University of London, London E1 2AT, UK.

出版信息

Retina. 2013 May;33(5):901-10. doi: 10.1097/IAE.0b013e3182870c15.

DOI:10.1097/IAE.0b013e3182870c15
PMID:23609064
Abstract

BACKGROUND/PURPOSE: Retinal vein occlusion is the second most common retinal vascular disorder after diabetic retinopathy and is considered to be an important cause of visual loss. In this review, the purpose is to make an update of the literature about the classification, epidemiology, pathogenesis, risk factors, clinical features, and complications of branch retinal vein occlusion (BRVO).

METHODS

Eligible articles were identified using a comprehensive literature search of MEDLINE, using the terms "branch retinal vein occlusion," "pathogenesis," "epidemiology," "risk factors," "clinical features," "diagnosis," and "complications." Additional articles were also selected from reference lists of articles identified by the electronic database search.

RESULTS

Classification, epidemiology, pathogenesis, risk factors, clinical features, and complications are analyzed.

CONCLUSIONS

Branch retinal vein occlusion has an incidence of 0.5% to 1.2%. Several risk factors, such as hypertension, hyperlipidemia, diabetes mellitus, thrombophilia and hypercoagulation, systemic and inflammatory diseases, medications, and ocular conditions, have found to be associated with BRVO. The symptoms depended on the site and severity of the occlusion. The average reduction in visual acuity for ischemic BRVO is 20/50 and for nonischemic BRVO is 20/60. Acute BRVO can be detected by fundoscopy, where flame hemorrhages, dot and blot hemorrhages, cotton wool spots, hard exudates, retinal edema, and dilated tortuous veins can be observed. Chronic BRVO would be more subtle and characterized by the appearance of venous collateral formation and vascular sheathing, in addition to complications previously mentioned. Areas of ischemia can be evaluated using fluorescein angiography. The extent of macular edema and the presence of retinal detachment can be detected by fundoscopic examination or fluorescein angiography, although optical coherence tomography is considered to be the best method. As far as complications, the most common is macular edema, followed by retinal neovascularization, vitreous hemorrhage, or retinal detachment.

摘要

背景/目的:视网膜静脉阻塞是仅次于糖尿病性视网膜病变的第二大常见视网膜血管疾病,被认为是视力丧失的重要原因。在这篇综述中,目的是对分支视网膜静脉阻塞(BRVO)的分类、流行病学、发病机制、危险因素、临床特征和并发症的文献进行更新。

方法

通过对 MEDLINE 进行全面的文献检索,使用“分支视网膜静脉阻塞”、“发病机制”、“流行病学”、“危险因素”、“临床特征”、“诊断”和“并发症”等术语,确定符合条件的文章。还从电子数据库搜索确定的文章参考文献列表中选择了其他文章。

结果

分析了分类、流行病学、发病机制、危险因素、临床特征和并发症。

结论

分支视网膜静脉阻塞的发病率为 0.5%至 1.2%。高血压、高血脂、糖尿病、血栓形成和高凝状态、全身和炎症性疾病、药物和眼部疾病等几种危险因素已被发现与 BRVO 相关。症状取决于阻塞的部位和严重程度。缺血性 BRVO 的平均视力下降为 20/50,非缺血性 BRVO 的平均视力下降为 20/60。急性 BRVO 可通过眼底镜检查发现,可观察到火焰状出血、点状和斑片状出血、棉絮斑、硬性渗出物、视网膜水肿和扩张迂曲的静脉。慢性 BRVO 更为微妙,除了先前提到的并发症外,还表现为静脉侧支形成和血管鞘的出现。可以使用荧光素血管造影评估缺血区域。可以通过眼底检查或荧光素血管造影检测黄斑水肿程度和视网膜脱离的存在,尽管光相干断层扫描被认为是最好的方法。至于并发症,最常见的是黄斑水肿,其次是视网膜新生血管、玻璃体积血或视网膜脱离。

相似文献

1
Branch retinal vein occlusion: epidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature.视网膜分支静脉阻塞:流行病学、发病机制、危险因素、临床特征、诊断和并发症。文献更新。
Retina. 2013 May;33(5):901-10. doi: 10.1097/IAE.0b013e3182870c15.
2
Branch retinal vein occlusion: treatment modalities: an update of the literature.视网膜分支静脉阻塞:治疗方式:文献综述
Semin Ophthalmol. 2014 Mar;29(2):85-107. doi: 10.3109/08820538.2013.833271. Epub 2013 Oct 30.
3
Branch retinal vein occlusion.视网膜分支静脉阻塞
J Ayub Med Coll Abbottabad. 2008 Apr-Jun;20(2):128-32.
4
Response of retinal vessels and retrobulbar hemodynamics to intravitreal anti-VEGF treatment in eyes with branch retinal vein occlusion.抗 VEGF 药物玻璃体腔内注射治疗对视网膜分支静脉阻塞患眼视网膜血管及球后血流动力学的影响
Invest Ophthalmol Vis Sci. 2011 May 9;52(6):3046-50. doi: 10.1167/iovs.10-5842.
5
Morphologic and functional changes in retinal vessels associated with branch retinal vein occlusion.与分支视网膜静脉阻塞相关的视网膜血管形态和功能变化。
Ophthalmology. 2013 Jan;120(1):91-9. doi: 10.1016/j.ophtha.2012.06.054. Epub 2012 Sep 12.
6
Usefulness of indocyanine green angiography to depict the distant retinal vascular anomalies associated with branch retinal vein occlusion causing serous macular detachment.吲哚菁绿血管造影在显示分支静脉阻塞引起浆液性黄斑脱离的远端视网膜血管异常中的作用。
Retina. 2012 Feb;32(2):308-13. doi: 10.1097/IAE.0b013e31821c40a9.
7
Serous macular detachment in branch retinal vein occlusion.视网膜分支静脉阻塞中的浆液性黄斑脱离
Retina. 2006 Nov-Dec;26(9):1029-33. doi: 10.1097/01.iae.0000254893.94013.16.
8
Retinal vein occlusion.视网膜静脉阻塞
Am Fam Physician. 1992 Jun;45(6):2661-6.
9
Long-term study of vascular perfusion effects following arteriovenous sheathotomy for branch retinal vein occlusion.分支型视网膜静脉阻塞行动静脉鞘切开术后血管灌注效果的长期研究。
Acta Ophthalmol. 2010 May;88(3):e57-65. doi: 10.1111/j.1755-3768.2010.01877.x. Epub 2010 Mar 8.
10
Pathophysiology and hemodynamics of branch retinal vein occlusion.视网膜分支静脉阻塞的病理生理学与血流动力学
Ophthalmology. 1999 Nov;106(11):2054-62. doi: 10.1016/S0161-6420(99)90483-9.

引用本文的文献

1
Exploring the role of oxidative stress in retinal vein occlusion: an updated and comprehensive review on the pathophysiology and treatment perspectives.探索氧化应激在视网膜静脉阻塞中的作用:关于病理生理学和治疗前景的最新综合综述
Int Ophthalmol. 2025 Aug 28;45(1):358. doi: 10.1007/s10792-025-03687-z.
2
Unilateral branch retinal vein occlusion and contralateral branch retinal artery occlusion: a case report and comprehensive literature review.单侧视网膜分支静脉阻塞与对侧视网膜分支动脉阻塞:一例报告及文献综述
Front Med (Lausanne). 2025 Jul 22;12:1615871. doi: 10.3389/fmed.2025.1615871. eCollection 2025.
3
Concurrent Onset of Central Retinal Vein Occlusion and Inflammation of a Large Maxillary Odontogenic Cyst: Case Report and Analysis.
视网膜中央静脉阻塞与巨大上颌牙源性囊肿炎症并发:病例报告与分析
Reports (MDPI). 2024 Jul 14;7(3):55. doi: 10.3390/reports7030055.
4
Widefield OCT angiography.广角光学相干断层扫描血管造影术
Prog Retin Eye Res. 2025 Jul;107:101378. doi: 10.1016/j.preteyeres.2025.101378. Epub 2025 Jun 13.
5
Comparison of three loading doses of bevacizumab and ranibizumab for macular edema due to branch retinal vein occlusion.三种负荷剂量的贝伐单抗和雷珠单抗治疗视网膜分支静脉阻塞所致黄斑水肿的比较
BMC Ophthalmol. 2025 May 22;25(1):304. doi: 10.1186/s12886-025-04126-4.
6
Risk factors and incidence of Macular Edema in eyes with retinal Vein Occlusion after uneventful cataract surgery: The MEVO study.白内障手术平稳进行后视网膜静脉阻塞患者眼中黄斑水肿的危险因素及发生率:MEVO研究
Indian J Ophthalmol. 2025 Jun 1;73(6):864-869. doi: 10.4103/IJO.IJO_1700_24. Epub 2025 Apr 17.
7
Construction and validation of risk prediction models for different subtypes of retinal vein occlusion.视网膜静脉阻塞不同亚型风险预测模型的构建与验证
Adv Ophthalmol Pract Res. 2025 Mar 17;5(2):107-116. doi: 10.1016/j.aopr.2025.03.003. eCollection 2025 May-Jun.
8
Intravitreal Dexamethasone Implant for Patients With Central Retinal Vein Occlusion: Four-Year Outcomes in a Real-World Study.玻璃体内注射地塞米松植入物治疗视网膜中央静脉阻塞患者:一项真实世界研究的四年结果
Cureus. 2025 Mar 11;17(3):e80391. doi: 10.7759/cureus.80391. eCollection 2025 Mar.
9
Risk of Retinal Vein Occlusion between Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors in Type 2 Diabetes: A Retrospective Cohort Study.2型糖尿病患者中胰高血糖素样肽-1受体激动剂与二肽基肽酶-4抑制剂相比发生视网膜静脉阻塞的风险:一项回顾性队列研究
Ophthalmol Sci. 2025 Feb 7;5(4):100734. doi: 10.1016/j.xops.2025.100734. eCollection 2025 Jul-Aug.
10
Association Between Contrast Sensitivity and Ganglion Cell-Inner Plexiform Layer Thickness After Resolution of Macular Edema Due to Branch Retinal Vein Occlusion.视网膜分支静脉阻塞所致黄斑水肿消退后对比敏感度与神经节细胞-内丛状层厚度之间的关联
J Clin Med. 2025 Feb 24;14(5):1507. doi: 10.3390/jcm14051507.